--- title: "诺和诺德哥本哈根股价(NOVOB.DC)收跌 1.81%,报 308.80 丹麦克朗,本周累计下跌 31.70%,创公司丹麦 IPO 以来最差单周表现。同时,该公司在发布业绩报告时宣布提拔内部高管为新" description: "诺和诺德哥本哈根股价(NOVOB.DC)收跌 1.81%,报 308.80 丹麦克朗,本周累计下跌 31.70%,创公司丹麦 IPO 以来最差单周表现。同时,该公司在发布业绩报告时宣布提拔内部高管为新 CEO。此外,美国总统特朗普要求医药公司降低美国市场药品价格。" type: "news" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/251238721.md" published_at: "2025-08-01T17:40:05.000Z" --- # 诺和诺德哥本哈根股价(NOVOB.DC)收跌 1.81%,报 308.80 丹麦克朗,本周累计下跌 31.70%,创公司丹麦 IPO 以来最差单周表现。同时,该公司在发布业绩报告时宣布提拔内部高管为新 > 诺和诺德哥本哈根股价(NOVOB.DC)收跌 1.81%,报 308.80 丹麦克朗,本周累计下跌 31.70%,创公司丹麦 IPO 以来最差单周表现。同时,该公司在发布业绩报告时宣布提拔内部高管为新 CEO。此外,美国总统特朗普要求医药公司降低美国市场药品价格。 诺和诺德哥本哈根股价(NOVOB.DC)收跌 1.81%,报 308.80(丹麦克朗),本周累计下跌 31.70%,创该公司丹麦 IPO 以来最差单周表现。 本周,该公司在发布业绩报告时宣布,提拔内部高管为新 CEO。 随后,美国总统特朗普要求众多医药公司在美国市场降低药品价格。 ### Related Stocks - [NVO.US - 诺和诺德公司](https://longbridge.com/zh-CN/quote/NVO.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? | As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? | [Link](https://longbridge.com/zh-CN/news/270794581.md) | | Novo Nordisk (NVO) Rethinks Pricing as Compounded GLP-1 Drugs Gain Ground | Novo Nordisk CEO Mike Doustdar announced that 1.5 million people in the U.S. are using compounded GLP-1 weight-loss drug | [Link](https://longbridge.com/zh-CN/news/272307926.md) | | OXY-Clean: Buffett's Favourite Oil Rig Scrubs $6 Billion In Debt Off The Books | Occidental Petroleum Corp (NYSE:OXY) has significantly reduced its debt by $5.8 billion after selling its OxyChem divisi | [Link](https://longbridge.com/zh-CN/news/276372720.md) | | Palantir spent $25M on CEO flights so Alex Karp could do all the talking | Palantir CEO Alex Karp has spent nearly $25 million on private flights over two years to maintain his visibility in the | [Link](https://longbridge.com/zh-CN/news/276359392.md) | | BUZZ-Street View: Booking Holdings may be shielded from AI disruption noise | Booking Holdingssurpassed Q4 profit expectations, driven by strong international travel demand. RBC Capital Markets sugg | [Link](https://longbridge.com/zh-CN/news/276333390.md) | --- > **免责声明**:本文内容仅供参考,不构成任何投资建议。